Related Experiment Video
Updated: Dec 10, 2025

06:18
Multiplexed Isothermal Amplification Based Diagnostic Platform to Detect Zika, Chikungunya, and Dengue 1
Published on: March 13, 2018
14.7K
ddRFC: A scalable multiplexed droplet digital nucleic acid amplification test platform.
Ye Zhang1, Pengfei Zhang1, Liben Chen2
1Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, 21218, USA.
Biosensors & Bioelectronics
|August 27, 2020
Summary
A new digital nucleic acid amplification test (digital NAAT) platform, Droplet Digital Ratiometric Fluorescence Coding (ddRFC), enables multiplexed detection of multiple nucleic acid targets. This cost-effective method enhances diagnostic capabilities for diseases like STIs.
Area of Science:
- Molecular Biology
- Biotechnology
- Diagnostics
Background:
- Current digital nucleic acid amplification tests (digital NAATs) typically use a "one-color-one-target" approach, limiting multiplexing due to spectral overlap issues.
- Scaling multiplexability in digital NAATs is challenging, hindering the simultaneous detection of multiple nucleic acid targets.
Purpose of the Study:
- To develop a multiplexed digital NAAT platform capable of detecting multiple nucleic acid targets simultaneously.
- To overcome the limitations of single-plex detection in current digital NAAT platforms.
Main Methods:
- Developed Droplet Digital Ratiometric Fluorescence Coding (ddRFC), a padlock probe-based nucleic acid detection assay.
- Encoded each nucleic acid target with a unique two-color fluorescence signature using two fluorophores.
- Performed digital amplification in microfluidic droplets to detect the encoded fluorescence signatures.
Main Results:
- Demonstrated broad-based, two-plex, four-plex, and six-plex detection of sexually transmitted infection (STI) targets with single-molecule resolution.
- Successfully synthesized six distinct padlock probes, each yielding a unique two-color fluorescence signature.
- Validated the ddRFC platform's ability to achieve high multiplexing without redesigning amplification primers or fluorescent molecular beacons.
Conclusions:
- The ddRFC platform offers a cost-effective strategy to scale multiplexability in digital NAATs by adjusting molecular beacon binding sites.
- This innovative approach has the potential for highly multiplexed nucleic acid detection with potentially unrestricted multiplexability.
- The ddRFC platform could serve as a valuable diagnostic tool for a wider range of diseases in the future.

